SREBF1 and obesity disorder: Since overexpression of either SREBP-1c or SREBP-1a in mouse liver markedly increased the expression of lipogenic genes and causes massive hepatosteatosis [55], hyperinsulinemia in obesity or early stage of T2DM would stimulate the expression of SREBP-1, thus leading to the development of steatosis.